Research shows world-first breakthrough for bowel cancer immunotherapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Dec-2025 23:11 ET (26-Dec-2025 04:11 GMT/UTC)
Researchers at the University of Galway have revealed the results of a world-first study into how bowel cancer shuts down the immune system, and how this can be reversed to improve treatment.
The findings have been published in the Journal for ImmunoTherapy of Cancer (JITC).
The research team showed how structural stromal cells switch off the immune system and how the body’s own killer cells can be switched back on, opening up the opportunity for a completely new approach to optimising immunotherapy for patients.
By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for years. But until recently, scientists didn’t understand which brain cells were being targeted or when the injury began.